04:22 PM EDT, 07/14/2025 (MT Newswires) -- Patrick Burnett, Executive Vice President and Chief Medical Officer, on July 10, 2025, sold 28,750 shares in Arcutis Biotherapeutics ( ARQT ) for $432,700. Following the Form 4 filing with the SEC, Burnett has control over a total of 115,468 common shares of the company, with 115,468 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1787306/000178730625000106/xslF345X05/wk-form4_1752523337.xml